JNJ Talc Suit Dismissal Sparks Market Watch as Crypto Assets Hold Steady
Johnson & Johnson shares dipped 0.19% to $227.29 after a federal court dismissed talc-related fraud claims, though the pharmaceutical giant still faces $1.5B in pending asbestos litigation. The ruling removes immediate liability concerns but maintains scrutiny on JNJ's 'Texas two-step' bankruptcy strategy for mass torts.
Meanwhile, cryptocurrency markets showed muted reaction to the news, with major assets like BTC and ETH holding support levels. Traders continue monitoring macro risks including Medicare drug pricing reforms that could impact traditional equity flows into digital assets.
Income investors note JNJ's February 24 ex-dividend date remains unaffected, with the $1.19/share payout locked for March 10. The stability contrasts with crypto staking yields currently offering 3-12% APY on platforms like Coinbase and Binance for assets including SOL and DOT.
